Kenneth Thomas Locke - 01 Jul 2026 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Jul 2026, 16:02:26 UTC
Prior SEC filing
10 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Todd Girolamo, attorney in fact

Key filing fact

Kenneth Thomas Locke filed Form 4 for PROKIDNEY CORP. (PROK) on 06 Jul 2026.

Key facts

  • This page summarizes Kenneth Thomas Locke's Form 4 filing for PROKIDNEY CORP. (PROK).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 06 Jul 2026, 16:02.

Change

  • Previous filing in this sequence was filed on 10 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002139380 Primary reporting owner

Locke Kenneth Thomas

Relationship
Chief Technical Officer
Address
2000 FRONTIS PLAZA BLVD, SUITE 250, WINSTON-SALEM
Signature
/s/ Todd Girolamo, attorney in fact
Signature date
06 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PROK transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
Shares
+750,000
Change %
Price
$0.000000*
Shares after
750,000
Date
01 Jul 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
750,000
Exercise price
$1.89
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests 25% on 1st anniversary of July 1, 2026 and the remaining 75% vests in substantially equal monthly installments for 36 months thereafter, subject to continued employment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .